Tumour expression of leptin associated with chemotherapy resistance

February 26, 2014, Cancer Research UK

Patients with the most common type of oesophageal cancer are less likely to respond to chemotherapy when their tumours are high in a protein called leptin, according to research published in the British Journal of Cancer.

Researchers from the University of Aberdeen studied more than 150 patients with adenocarcinomas and found that those tumours with higher amounts of – produced by fat cells – were less likely to be shrunk by chemotherapy.

Patients whose tumours had low levels of the leptin protein were more likely to benefit from chemotherapy.

Researchers also found that while patients with tumours high in leptin responded poorly to chemotherapy, they did have better survival rates regardless of treatment, whereas those with less leptin were more likely to have more aggressive tumours.

The researchers believe that measuring levels of leptin could help doctors decide which oesophageal cancer patients would benefit from chemotherapy and may even be a target for new drug treatments. It may also help explain the link between increased body weight and increased oesophageal cancer risk.

Dr Russell Petty, a consultant medical oncologist and study author, said: "Our work suggests that having low levels of leptin means that the is more likely to be aggressive but also that it is more likely to respond well to chemotherapy. Knowing who will benefit most from chemotherapy will prevent many patients from undergoing treatment unnecessarily, and could allow us to try alternative, and potentially more effective, treatments in patients in whom chemotherapy is unlikely to be successful – essentially tailoring the treatment to individual patients.

"Oesophageal cancers, particularly adenocarcinomas, are on the rise in the UK and we desperately need to do more research to help improve the outcome for our patients, which remains relatively poor."

Oesophageal cancer is the thirteenth most common cancer in the UK with around 8,300 new cases diagnosed in the UK every year. It is also the sixth most common cause of cancer death. Adenocarcinomas are the most common type of oesophageal cancer in the UK.

Martin Ledwick, Cancer Research UK's head information nurse, said: "We know that does not help all oesophageal cancer patients so any research that helps us understand who to target with other types of therapy will be a big help to doctors.

"Many people with oesophageal cancer are diagnosed too late for treatment to be successful which is why we're urging people to be aware of the symptoms. Things like difficulty swallowing or food coming back up, persistent heartburn, unexplained weight loss, a hoarse voice or persistent cough, coughing up blood, or a pain or discomfort in the throat or back should be checked out with your GP. It most likely won't be but it's a good idea to get it looked at just in case."

Explore further: More oesophageal cancer patients benefit from pre-op chemo than previously thought says study

More information: Bain, GH et al., "Tumour expression of Leptin is associated with chemotherapy resistance and therapy independent prognosis in gastroesophageal adenocarcinomas." (2014) British Journal of Cancer.

Related Stories

More oesophageal cancer patients benefit from pre-op chemo than previously thought says study

December 23, 2013
More oesophageal cancer patients than previously thought are benefiting from having chemotherapy before an operation to remove their tumour, according to new research published in the World Journal of Gastroenterology.

Deaths from oesophageal cancer up by almost 50 per cent in last 40 years

January 6, 2014
The number of people dying from oesophageal cancer – cancer of the gullet or food pipe – has risen by 49 per cent in the last 40 years according to new figures published by Cancer Research UK, today.

Patients with mouth and oesophageal cancers take longer to seek help from GP

February 11, 2014
People with cancers of the mouth and oesophagus are waiting longer between first noticing a symptom and going to their GPs compared to patients with other types of cancers, according to research published in the International ...

Classification system for bladder cancer prognosis

January 29, 2014
Researchers at Lund University have developed a classification system to determine the prognosis for bladder cancer. It is hoped that this will prove useful for future bladder cancer research and drug development.

New research shows 'DNA tags' could guide treatment for advanced ovarian cancer

October 15, 2013
A Cancer Research UK study has identified chemical 'tags' on DNA in patients' tumours that could help doctors decide the type of chemotherapy women with advanced ovarian cancer should receive, according to a new paper published ...

Metal implants may cut chemotherapy side effects, study suggests

February 13, 2014
Cancer patients could one day experience fewer side effects from chemotherapy following a discovery that opens the door for more targeted treatments.

Recommended for you

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Dietary fat, changes in fat metabolism may promote prostate cancer metastasis

January 15, 2018
Prostate tumors tend to be what scientists call "indolent" - so slow-growing and self-contained that many affected men die with prostate cancer, not of it. But for the percentage of men whose prostate tumors metastasize, ...

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.